LIANBIO's ticker is and the CUSIP is 53000N108. A total of 38 filers reported holding LIANBIO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,491 | -34.7% | 1,001 | 0.0% | 0.00% | – |
| Q2 2023 | $2,282 | +16.3% | 1,001 | 0.0% | 0.00% | – |
| Q1 2023 | $1,962 | +19.5% | 1,001 | 0.0% | 0.00% | – |
| Q4 2022 | $1,642 | -98.5% | 1,001 | -98.2% | 0.00% | – |
| Q3 2022 | $110,000 | +5400.0% | 55,146 | +5409.1% | 0.00% | – |
| Q2 2022 | $2,000 | -86.7% | 1,001 | -75.1% | 0.00% | – |
| Q1 2022 | $15,000 | – | 4,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,282,084 | $4,472,885 | 6.12% |
| Perceptive Advisors | 57,558,451 | $112,814,563 | 3.33% |
| SCHF (GPE), LLC | 937,500 | $1,838 | 3.24% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,303,573 | $6,475,003 | 0.65% |
| Cormorant Asset Management, LP | 4,250,000 | $8,330 | 0.55% |
| Affinity Asset Advisors, LLC | 650,000 | $1,267,500 | 0.42% |
| 22NW, LP | 141,223 | $276,797 | 0.17% |
| MYDA Advisors LLC | 120,000 | $235,200 | 0.09% |
| Logos Global Management LP | 280,000 | $548,800 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 209,600 | $410,816 | 0.06% |